Edifice Health
Imagine A World Without Chronic Disease
- Business Model
- B2B
- Website
- edificehealth.com
- Total Funding
- $12.0M
- Last Round
- $12.0M Series AApr 2021
- Rounds
- 1
About
Edifice Health enables patients to measure and monitor their inflammatory health, helping to proactively manage chronic inflammation for better overall health and longevity. The novel Inflammatory Age® test is derived from a 10 year NIH funded longitudinal research from Stanford University, the Stanford 1,000 Immunomes Project. Using state-of-the-art 'omics' platforms and advanced artificial intelligence methods, the Stanford team developed the world's first biomarker composite scoring system to measure inflammatory and immune health of an individual.
Summary
Edifice Health is a Biotech company. It has raised $12.0M in total across 1 round, most recently a $12.0M Series A round in Apr 2021. Investors include Leaps by Bayer, Paladin Capital Group and Ahren Innovation Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2021
Investors
Similar Companies
China's leading blood products manufacturer

IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...

Specialty pharmaceutical company
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/edifice-health"><img src="https://indexed.vc/api/badge/company/edifice-health" alt="Edifice Health on Indexed.vc" width="260" height="76" /></a>

